ATARA BIOTHERAPEUTICS, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-119.5M | $-79.0M | $-57.2M | $-28.0M | $-8.8M |
| Depreciation & Amortization | $956.0K | $383.0K | $48.0K | — | — |
| Depreciation | — | $383.0K | $48.0K | $6.0K | $4.0K |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $23.1M | $16.8M | $10.3M | $10.1M | $1.7M |
| Net Cash from Operating Activities | $-87.5M | $-60.0M | $-37.2M | $-16.6M | $-6.0M |
| Investing Activities | |||||
| Capital Expenditures | $20.2M | $3.0M | $290.0K | $46.0K | $3.0K |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $99.9M | $83.7M | — | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $20.0M | $506.0K | — | — | — |
| Net Change in Cash | $31.3M | $24.2M | $1.8M | $-29.7M | $47.4M |
| Free Cash Flow | $-107.7M | $-63.0M | $-37.4M | $-16.7M | $-6.0M |